Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Affymetrix license denied in U.K.

The English High Court today ruled that AFFX does not have a license to DNA microarray patents belonging to Oxford Gene Technology (Oxford, U.K.), removing one of AFFX's defenses in a patent infringement lawsuit brought by Oxford Gene in

Read the full 394 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers